Global DNA and Gene Chip (Microarrays)
DNA microarrays are an innovation used to quantify the expression levels of a large number of qualities together and now and again, all qualities in a genome in the meantime. There are two sorts of DNA microarrays, cDNA (correlative DNA), and oDNA (oligonucleotide DNA) with oDNA overwhelming the business sector with an offer of just about 98%. The worldwide DNA and quality chip (Microarray) market offers huge development potential and has seen the passage of various players taking a stab at an offer in this business sector.
The worldwide DNA and quality chip (microarray) business sector was esteemed at $760 million in 2010 and is relied upon to reach $1,425.2 million by 2015 developing at a CAGR of and 13.4%. Quality expression right now frames the biggest application market as quality expression items have assorted use in regions, for example, clinical diagnostics, biodefense, and farming that are increasing colossal government subsidizing. While this application contributed 28% to the worldwide DNA and quality chip (microarray) market incomes in 2010, tumor finding and treatment application is relied upon to overwhelm the applications market by 2015; representing around 24% offer in the business sector
Related Conference of Global DNA and Gene Chip (Microarrays)
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
17th International Conference on Human Genetics and Genetic Diseases
Global DNA and Gene Chip (Microarrays) Conference Speakers
Recommended Sessions
- Bioprocess Engineering and Biomarkers
- Cancer Genomics
- Chromosomal Abnormalities
- Clinical applications and diagnostics
- Cytogenetics
- Ecogenomics
- Evolution of Novel Genes
- Gene Expression, Regulation And Cloning
- Gene Mapping
- Genetic counseling
- Genetic Disorders Tests
- Genetic engineering techniques
- Genetic Testing Market
- Genetically modified organisms
- Genomic analysis
- Genomic data
- Genomic medicine
- Global DNA and Gene Chip (Microarrays)
- Medical genomics
- Microbial genetics
- Molecular Medicine
- Next generation sequencing
- Novel medical Devices
- Pedigree Methods
- Personalised genomics
- Pharmacogenetics
- Polygenic inheritance
- Prenatal diagnosis
- Reprogenetics
- Teratogenesis and their effects
- Tissue culture techniques
- Tissue Engineering and Regeneration
- Transgenic Research
- Tumor Markers
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)

